Eudralex Volume 3 Public Statement on the Evaluation of Bovine Spongiform Encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines
Titel:
Eudralex Volume 3 Public Statement on the Evaluation of Bovine Spongiform Encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines
Internet:
Herkunft/Verlag:
European Commission Enterprise and Industry DG, BREY 13/ 092, B - 1049 Brussels (Belgium), http://ec.europa.eu/enterprise/
Dokumentenart:
öffentliche Stellungnahme
Inhalt:
Ermittlung des BSE Risikos beim Gebrauch von Material bovinen Ursprungs bei der Impfstoffherstellung